Nrx Pharmaceuticals Inc (NRXP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Nrx Pharmaceuticals Inc Azioni (NRXP) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-03-31	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi
Revenues	-	-	-
Income/Loss From Continuing Operations Before Tax	30.20% -5.512	-7.897	-6.528
Income Tax Expense/Benefit	-	-	-
Income/Loss From Continuing Operations After Tax	30.20% -5.512	-7.897	-6.528
Net Income/Loss	30.20% -5.512	-7.897	-6.528
Preferred Stock Dividends And Other Adjustments	-	-	-
Attributable To Noncontrolling Interest	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-

RPRX

$44.80

1.24%

ROIV

$26.75

0.19%

INCY

$100.75

1.93%

BNTX

$105.76

3.31%

INSM

$146.17

1.52%

ONC

$346.42

1.38%